MARKET

ATHA

ATHA

Athira Pharma, Inc.
NASDAQ
7.57
+0.55
+7.83%
After Hours: 7.47 -0.1 -1.32% 18:43 12/31 EST
OPEN
7.09
PREV CLOSE
7.02
HIGH
7.64
LOW
7.08
VOLUME
132.58K
TURNOVER
--
52 WEEK HIGH
8.36
52 WEEK LOW
2.195
MARKET CAP
29.86M
P/E (TTM)
-0.7823
1D
5D
1M
3M
1Y
5Y
1D
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—12/31/25
TipRanks · 12/31/2025 12:43
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—12/30/25
TipRanks · 12/30/2025 11:59
Vanguard Total Stock Market ETF (VTI) Daily Update—12/29/25
TipRanks · 12/29/2025 12:46
Weekly Report: what happened at ATHA last week (1222-1226)?
Weekly Report · 12/29/2025 10:20
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 12/26/2025 12:05
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—12/24/25
TipRanks · 12/24/2025 12:36
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—12/23/25
TipRanks · 12/23/2025 12:00
Vanguard Total Stock Market ETF (VTI) Daily Update—12/22/25
TipRanks · 12/22/2025 13:05
More
About ATHA
Athira Pharma, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing small molecules to restore neuronal health and slow neurodegeneration. Its approach is designed to modulate the neurotrophic hepatocyte growth factor (HGF) system, which is critical to normal brain function. The Company’s lead drug candidate is ATH-1105. ATH-1105 is a novel, orally available, brain-penetrant small-molecule drug candidate designed to positively modulate the neurotrophic HGF system for the potential treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), Alzheimer’s disease (AD), and Parkinson’s disease (PD). ATH-1105 is in development for the potential treatment of ALS. Its ATH-1020 is a novel, orally available small molecule drug candidate designed to positively modulate the neurotrophic HGF system. It has evaluated several other compounds in preclinical discovery and development for neurodegenerative diseases and other indications.

Webull offers Athira Pharma Inc stock information, including NASDAQ: ATHA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ATHA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ATHA stock methods without spending real money on the virtual paper trading platform.